Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Toxicity study and blood pressure-lowering efficacy of whey protein concentrate hydrolysate in rat models, plus peptide characterization

J Dairy Sci.. 2019; 
Hussein FA1, Chay SY2, Ghanisma SBM2, Zarei M3, Auwal SM4, Hamid AA2, Ibadullah WZW2, Saari N5.
Products/Services Used Details Operation
Peptide Synthesis Eight potentially potent peptide samples were chemically synthesized by a commercial peptide supplier (GenScript, Piscataway, NJ) at a final purity of greater than 90%. Get A Quote

摘要

We evaluated the acute (single-dose) and subacute (repeated-dose) oral toxicity of alcalase-hydrolyzed whey protein concentrate. Our acute study revealed no death or treatment-related complications, and the median lethal dose of whey protein concentrate hydrolysate was >2,500 mg/kg. In the subacute study, when the hydrolysate was fed at 3 different concentrations (200, 400, and 800 mg/kg), no groups showed toxicity changes compared with controls. Then, whey protein concentrate hydrolysate was orally administered to spontaneously hypertensive rats. Results revealed significant reductions in blood pressure in a dose-dependent manner, and dosing at 400 mg/kg led to significant blood pressure reduction (-47.8 mm Hg... More

关键词

angiotensin-converting enzyme (ACE) inhibition; bioactive peptide; hydrolysis; rat study; whey protein concentrate
XML 地图